BackgroundCheck.run
Search For

Fang Zhang, 4560 Durham Rd, Montgomery, NJ 08558

Known as:
Fang Zhao Zhang Fang
Related to:
Xijin Pang

Fang Zhang Phones & Addresses

60 Durham Rd, Skillman, NJ 08558   

Princeton, NJ   

Princeton Junction, NJ   

1820 Franklin Run Ct, Pittsburgh, PA 15237    412-3695392   

Tucker, GA   

Wexford, PA   

Atlanta, GA   

Get Report
Control this profile

Mentions for Fang Zhang

Career records & work history

Lawyers & Attorneys

Fang Zhang Photo 1

Fang Zhang - Lawyer

Specialties:
Contracts & Agreements, Corporate & Incorporation, Entertainment, Entertainment, Estate Planning, Intellectual Property, Real Estate
ISLN:
922383671
Admitted:
2011

Publications & IP owners

Us Patents

G-Protein Coupled Receptor Ligands And Methods

US Patent:
7338772, Mar 4, 2008
Filed:
Apr 10, 2003
Appl. No.:
10/411545
Inventors:
Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33/566
US Classification:
435 721, 435 72, 436501
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

G-Protein Coupled Receptor Ligands And Methods

US Patent:
7807390, Oct 5, 2010
Filed:
Jan 7, 2008
Appl. No.:
11/970276
Inventors:
Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33/566
C07K 14/705
US Classification:
435 721, 435 71, 435 72, 436501
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Antibodies And Functional Fragments Thereof That Specifically Bind An Rf-Amide Peptide Or A Precursor Thereof

US Patent:
8133980, Mar 13, 2012
Filed:
Oct 1, 2010
Appl. No.:
12/896297
Inventors:
Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07K 16/00
C12P 21/08
US Classification:
5303879, 5303881, 53038815, 4241391
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Method Of Sequence Optimization For Improved Recombinant Protein Expression Using A Particle Swarm Optimization Algorithm

US Patent:
8326547, Dec 4, 2012
Filed:
Sep 30, 2010
Appl. No.:
12/894401
Inventors:
Xiaowu Liu - Nanjing, CN
Yun He - Nanjing, CN
Zhuying Wang - Monmouth Junction NJ, US
Chunjiao Wang - Nanjing, CN
Zhibing Liu - Nanjing, CN
Tianhui Xia - Edison NJ, US
Luquan Wang - East Brunswick NJ, US
Fang Liang Zhang - Fanwood NJ, US
Assignee:
Nanjingjinsirui Science & Technology Biology Corp. - Nanjing
International Classification:
G06F 19/10
G06F 19/00
US Classification:
702 19, 702 20
Abstract:
An improved gene sequence optimization method, the systematic optimization method, is described for boosting the recombinant expression of genes in bacteria, yeast, insect and mammalian cells. This general method takes into account of multiple, preferably most or all, of the parameters and factors affecting protein expression including codon usage, tRNA usage, GC-content, ribosome binding sequences, promoter, 5′-UTR, ORF and 3′-UTR sequences of the genes to improve and optimize the gene sequences to boost the protein expression of the genes in bacteria, yeast, insect and mammalian cells. In particular, the invention relates to a system and a method for sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm. The improved systematic optimization method can be incorporated into a software for more efficient optimization.

Homologous Recombination-Based Dna Cloning Compositions

US Patent:
8501454, Aug 6, 2013
Filed:
Jan 31, 2012
Appl. No.:
13/362382
Inventors:
Weiqiang Liu - Nanjing, CN
Ping Yang - Princeton NJ, US
Tao Wang - Nanjing, CN
Zhuying Wang - Monmouth Junction NJ, US
Wenzhu Chen - Nanjing, CN
Fang Liang Zhang - Fanwood NJ, US
Assignee:
Nanjingjinsirui Science & Technology Biology Corp. - Nanjing
International Classification:
C12N 1/20
C12N 9/18
C07K 17/00
C12N 15/64
US Classification:
4352521, 435197, 435 914, 530350
Abstract:
Methods and compositions for cloning a donor DNA molecule into an acceptor vector at a predetermined location are described. The methods are based on homologous recombination mediated by in vitro treatment of the donor DNA and the acceptor vector with an enzyme cocktail containing an exonuclease and a single-stranded DNA binding protein.

G-Protein Coupled Receptor And Methods

US Patent:
2001004, Nov 29, 2001
Filed:
Apr 16, 2001
Appl. No.:
09/835922
Inventors:
Fang Zhang - Fanwood NJ, US
Lin Luo - Edison NJ, US
Eric Gustafson - Annandale NJ, US
Yan-Hui Liu - Murray Hill NJ, US
Guodong Chen - North Brunswick NJ, US
International Classification:
A61K039/395
G01N033/567
US Classification:
424/143100, 435/007210
Abstract:
The present invention provides an isolated mammalian SP 168 receptor and ligands of the receptor. This invention further provides screening methods for identifying specific agonists and antagonists of the mammalian SP168 receptor. Also provided are agonists and antagonists of the SP168 receptor and methods useful for treating medical conditions caused or mediated by the SP168 receptor

G-Protein Coupled Receptor And Methods

US Patent:
2003005, Mar 27, 2003
Filed:
Sep 13, 2002
Appl. No.:
10/243106
Inventors:
Fang Zhang - Fanwood NJ, US
Lin Luo - Edison NJ, US
Assignee:
Schering Corporation
International Classification:
G01N033/567
A61K039/395
A61K039/385
A61K031/00
US Classification:
435/007210, 424/143100, 514/001000
Abstract:
The present invention provides an isolated mammalian SP174 receptor and ligands of the receptor. This invention further provides screening methods for identifying specific agonists and antagonists of the mammalian SP174 receptor. Also provided are agonists and antagonists of the SP174 receptor and methods useful for treating medical conditions caused or mediated by the SP174 receptor.

Engineered U6 And H1 Promoters

US Patent:
2005006, Mar 24, 2005
Filed:
Sep 22, 2004
Appl. No.:
10/947035
Inventors:
Fang Zhang - Fanwood NJ, US
Luquan Wang - East Brunswick NJ, US
International Classification:
C12Q001/68
A01K067/00
C07H021/02
C12N015/85
US Classification:
435006000, 435455000, 435320100, 435325000, 800008000, 536023100
Abstract:
Several engineered U6 and H1 promoters have been discovered. Using these engineered U6 and H1 promoters, anti-sense or siRNA can be expressed in a regulated way. In the absence of an inducer, the antisense or siRNA is not expressed by the promoters. In the presence of an inducer, the antisense or siRNA can be expressed by the promoters.

Possible Relatives

David Zhang  Dawei Zhang  Dazhi Zhang  De K Zhang  Da Q Zhang  Dachuan Zhang  Daijun Zhang  Fang E Meng  Fang M Lim  Fang Y Lin 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.